Determination of kidney function before tenofovir initiation: four-fold difference in need of tenofovir dose reduction depending on method used

J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):e21-3. doi: 10.1097/QAI.0b013e3182199f00.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adenine / administration & dosage
  • Adenine / adverse effects
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Adult
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • Dose-Response Relationship, Drug
  • Female
  • Glomerular Filtration Rate
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Humans
  • Kidney Diseases / diagnosis*
  • Male
  • Organophosphonates / administration & dosage
  • Organophosphonates / adverse effects
  • Organophosphonates / therapeutic use*
  • Retrospective Studies
  • Tenofovir

Substances

  • Anti-HIV Agents
  • Organophosphonates
  • Tenofovir
  • Adenine